LEARN MORE
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.
LEARN MOREClinical Trials
Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.
Follow Us on Twitter
Women who experience the baby blues have an increased risk of developing #PPD, This makes the distinction between t… t.co/FdGEFU2QzU